Minority Health Archive

Projecting Individualized Absolute Invasive Breast Cancer Risk in African American Women

Gail, Mitchell H. and Costantino, Joseph P. and Pee, David and Bondy, Melissa and Newman, Lisa and Selvan, Mano and Anderson, Garnet L. and Malone, Kathleen E. and Marchbanks, Polly A. and McCaskill-Stevens, Worta and Norman, Sandra A. and Simon, Michael S. and Spirtas, Robert and Ursin, Giske and Bernstein, Leslie (2007) Projecting Individualized Absolute Invasive Breast Cancer Risk in African American Women. Journal of the National Cancer Institute, 99 (23). pp. 1782-1792.

Full text not available from this repository.

Abstract

Background The Breast Cancer Risk Assessment Tool of the National Cancer Institute (NCI) is widely used for counseling and determining eligibility for breast cancer prevention trials, although its validity for projecting risk in African American women is uncertain. We developed a model for projecting absolute risk of invasive breast cancer in African American women and compared its projections with those from the Breast Cancer Risk Assessment Tool. Methods Data from 1607 African American women with invasive breast cancer and 1647 African American control subjects in the Women’s Contraceptive and Reproductive Experiences (CARE) Study were used to compute relative and attributable risks that were based on age at menarche, number of affected mother or sisters, and number of previous benign biopsy examinations. Absolute risks were obtained by combining this information with data on invasive breast cancer incidence in African American women from the NCI’s Surveillance, Epidemiology and End Results Program and with national mortality data. Eligibility screening data from the Study of Tamoxifen and Raloxifene (STAR) trial were used to determine how the new model would affect eligibility, and independent data from the Women’s Health Initiative (WHI) were used to assess how well numbers of invasive breast cancers predicted by the new model agreed with observed cancers. Results Tables and graphs for estimating relative risks and projecting absolute invasive breast cancer risk with confidence intervals were developed for African American women. Relative risks for family history and number of biopsies and attributable risks estimated from the CARE population were lower than those from the Breast Cancer Risk Assessment Tool, as was the discriminatory accuracy (i.e., concordance). Using eligibility screening data from the STAR trial, we estimated that 30.3% of African American women would have had 5-year invasive breast cancer risks of at least 1.66% by use of the CARE model, compared with only 14.5% by use of the Breast Cancer Risk Assessment Tool. The numbers of cancers predicted by the CARE model agreed well with observed numbers of cancers (i.e., it was well calibrated) in data from the WHI, except that it underestimated risk in African American women with breast biopsy examinations. Conclusions The CARE model usually gave higher risk estimates for African American women than the Breast Cancer Risk Assessment Tool and is recommended for counseling African American women regarding their risk of breast cancer.


Export/Citation:EndNote | BibTeX | Dublin Core | ASCII (Chicago style) | HTML Citation | OpenURL | Reference Manager
Social Networking:

Item Type: Article
Additional Information: Access to full text is subject to the publisher's access restrictions.
Uncontrolled Keywords: breast cancer; African American women; Breast Cancer Risk Assessment Tool; risks; Women’s Contraceptive and Reproductive Experiences (CARE)
Subjects: Health
Health > Public Health > Chronic Illness & Diseases > Cancer
Research
Related URLs:
Depositing User: Users 141 not found.
Date Deposited: 10 Feb 2008
Last Modified: 06 May 2011 12:57
Link to this item (URI): http://health-equity.lib.umd.edu/id/eprint/888

Actions (login required)

View Item